TABLE 4-4 Studies of Hepatitis B Vaccination Rates in Injection-Drug Users

Reference

Location

Sample; Design

Cross-sectional studies of vaccination rates

Seal et al., 2000

San Francisco, CA

135 under 30 years old, 96 at least 30 years old

 

 

Cross-sectional

Lum et al., 2008

San Francisco, CA

831 young IDUs

 

 

Cross-sectional

Kuo et al., 2004

Baltimore, MD

324 IDUs, NIDUs

 

 

Cross-sectional

Additional vaccination studies

Campbell et al., 2007

5 US cities

3,181

 

 

Cohort; vaccination protocol varied by city

Altice et al., 2005

New Haven, CT; mobile health van at SEP

134 HBV-negative IDUs

 

 

Observational

Des Jarlais et al., 2001

Anchorage, AK; New York City

AK cohort referred to clinic (350); New York City cohort offered on-site vaccination at SEP (36) + small cash incentives

 

 

Cohort

Hutchinson et al., 2004

Glasgow, Scotland, prison vaccination, community assessment

In 1999, offered HBV vaccination to all inmates; surveyed new injectors (within 5 years)

Abbreviations: HBV, hepatitis B virus; IDU, injection-drug user; NIDU, non-injection-drug user; SEP, syringe-exchange program.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement